EFFICACY AND SAFETY OF WEIGHT-BASED VERSUS FIXED-DOSE 4F-PCC FOR DIRECT ORAL ANTICOAGULANT REVERSAL

被引：0
作者：
Woodfield, Emily [1 ]
Thomas, Miranda [1 ]
Milkovits, Ashley [1 ]
Barnes, Chase [1 ]
McAllister, Kelly [2 ]
Hornsby, Matthew [1 ]
机构：
[1] Caril Roanoke Mem Hosp, Roanoke, VA USA
[2] Carilion Clin, Raonoke, VA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
10.1097/01.ccm.0000909004.36933.1b
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
819
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
[31]   Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal [J].
Elsamadisi, Pansy ;
Cepeda, Mark A. G. ;
Yankama, Tuyen ;
Wong, Adrian ;
Tran, Qua ;
Eche, Ifeoma Mary .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (03) :355-361
[32]   Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal [J].
Pansy Elsamadisi ;
Mark A. G. Cepeda ;
Tuyen Yankama ;
Adrian Wong ;
Qua Tran ;
Ifeoma Mary Eche .
American Journal of Cardiovascular Drugs, 2021, 21 :355-361
[33]   Cost-effective study comparing fixed versus weight-based dosing of 4-factor Prothrombin Complex Concentrate (4F-PCC) in patients with major bleeding associated with oral factor Xa (FXa) inhibitors [J].
Lu, Rongzhen ;
Defonte, Daniella ;
Yoo, Chris ;
Yuen, Chi Fai .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S550-S550
[34]   Evaluation of Four Factor Prothrombin Concentration Complex (4F-PCC) Usage in the Emergency Department for Anticoagulant Reversal [J].
Huizenga, Kristyn C. ;
Daberko, Jennifer ;
Palausky, Melissa .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S826-S827
[35]   COMPARISON OF 4F-PCC FOR REVERSAL OF DOAC VERSUS WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE [J].
Pasciolla, Stacy ;
Wojcik, Kevin ;
Evans, Danielle ;
Shaikh, Hamza ;
Jankowitz, Brian ;
Igneri, Lauren .
CRITICAL CARE MEDICINE, 2021, 49 (01) :352-352
[36]   Comparison of 4F-PCC and aPCC time to administration and outcomes for oral anticoagulant-related ICH [J].
Lin, Stacy ;
Cunningham, Brittany ;
Mullen, Chanda ;
Simon, Erin ;
Bice, Deanna ;
Garlock, Jenna .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 56 :183-187
[37]   SAFETY OF FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATES (4F-PCC) FOR THE REVERSAL OF FACTOR XA INHIBITORS [J].
Tao, Jing ;
Bukanova, Elena ;
Akhtar, Shamsuddin .
ANESTHESIA AND ANALGESIA, 2018, 126 (04) :98-100
[38]   Time to Administration of Four Factor Prothrombin Complex Concentrate (4F-PCC) for Reversal of Oral Anticoagulation [J].
Walker, Katharyn ;
Jones, Kerri .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S1448-S1448
[39]   Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors [J].
Tao, Jing ;
Bukanova, Elena N. ;
Akhtar, Shamsuddin .
JOURNAL OF INTENSIVE CARE, 2018, 6
[40]   Optimizing Enoxaparin Dosing in Trauma Patients: A Comparison of Fixed-Dose and Weight-Based Strategies [J].
Buchholz, Carl ;
Collier, Bryan R. ;
D'aquila, Madeline L. ;
Gates, Rebecca S. ;
Gillen, Jacob R. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) :S538-S538
12345